Alaska Permanent Fund Corp Vir Biotechnology, Inc. (VIR) insider trading activity

Alaska Permanent Fund Corp is of Vir Biotechnology, Inc.. Currently has a direct ownership of 5.56 Million shares of VIR, which is worth approximately $51.4 Million. The most recent transaction as insider was on Oct 16, 2019, when has been sold 1,500,000 shares (Common Stock) at a price of $20.0 per share, resulting in proceeds of $30,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).